Last September, another obesity-focused biotech, BioAge, completed an upsized IPO that raised $198 million, after the number of shares on offer was hiked by 40%. Metsera's lead asset is MET-097i ...

Its prospectus says that the IPO will fund phase 1 and phase 2a proof ... The two filings follow in the footsteps of obesity drug developer Metsera and genetic medicines developer Maze ...

Klarna, the specialty lending and online payments provider, has halted its planned initial public offering, the latest IPO casualty in the wake of the Trump administration’s sweeping tariff ...

As per Inc42 data, 20 startups are in various stages of undertaking their IPO preparations at the outset of 2025 Key factors that are likely to contribute to the public listing mania in 2025 are ...

We built our IPO process in partnership with the investment banking community, ensuring that they have the control and information they need to successfully open your IPO. Nasdaq’s best-in-class ...

xAI remains privately held, not tradable publicly; accredited investors can buy pre-IPO shares via secondary markets. Investment opportunities in AI include buying shares of firms like Nvidia ...

Millrose Properties is a Homesite Option Purchase Platform (“HOPP’R”), an evolution of residential land banking, accelerating homebuilders’ capital-efficient growth of controlled land ...

Reverse mergers typically occur through a simpler, shorter, and less expensive process than a conventional IPO. With an IPO, private companies hire an investment bank to underwrite and issue ...